KMTS vs TNDM: stock comparison and AI forecast
Kestra Medical Technologies, Ltd. (KMTS) and Tandem Diabetes Care Inc (TNDM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KMTS Kestra Medical Technologies, Ltd.
- Price
- $29.69 +43.3% · 6M
- Market Cap
- $1.77B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
TNDM Tandem Diabetes Care Inc
- Market Cap
- $1.33B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- KMTS is 1.3 times larger than TNDM by market capitalization ($1.77B against $1.33B).
- TNDM carries 7.85 times debt per unit of equity, against 0.56 times for KMTS.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KMTS | TNDM |
|---|---|---|
| Market Cap | $1.77B | $1.33B |
| P/B Ratio | 7.95x | 10.20x |
| EPS | $-2.68 | $-0.60 |
| Book Value/Share | $3.73 | $1.87 |
| Revenue/Share | $1.79 | $14.97 |
| FCF/Share | $-2.06 | $-0.38 |
Profitability & Margins
| Metric | KMTS | TNDM |
|---|---|---|
| ROE | -67.4% | – |
| ROA | -43.1% | – |
| ROIC | -48.0% | -5.1% |
| Gross Margin | 53.9% | 56.0% |
| Operating Margin | -134.5% | -4.4% |
| Net Margin | -140.4% | – |
| EBT Margin | -140.1% | -5.9% |
| Tax Rate | -0.2% | -3.8% |
Financial Health
| Metric | KMTS | TNDM |
|---|---|---|
| Current Ratio | 4.69x | 3.18x |
| Quick Ratio | – | 2.65x |
| D/E Ratio | 0.56x | 7.85x |
| Financial Leverage | 1.56x | 8.85x |
| Interest Coverage | -34.3x | 1.6x |
| Working Capital | $178M | $552M |
Cash Flow
| Metric | KMTS | TNDM |
|---|---|---|
| Operating Cash Flow | -$88M | -$6M |
| Free Cash Flow | -$123M | -$27M |
| Capital Spending | -$35M | -$21M |
| OCF Growth YoY | – | -156.8% |
| FCF/Sales | -115.0% | -2.6% |
| CapEx/Sales | 32.9% | 2.0% |
Operational Efficiency
| Metric | KMTS | TNDM |
|---|---|---|
| Asset Turnover | 0.31x | 0.90x |
| Receivables Turnover | 6.9x | 6.4x |
| Inventory Turnover | – | 3.4x |
| Fixed Assets Turnover | 1.7x | 12.3x |
| Days Sales Outstanding | 53 days | 57 days |
| Days Inventory | – | 108 days |
| Payables Period | 193 days | 51 days |
| Cash Conversion Cycle | – | 113 days |
Income Statement
| Metric | KMTS | TNDM |
|---|---|---|
| Total Revenue | $107M | $1.04B |
| Operating Income | -$144M | -$46M |
| Net Income | -$150M | – |
| R&D Expense | $22M | $188M |
| SG&A Expense | $179M | $441M |
| Cost of Goods Sold | $49M | $458M |
Dividend & Shareholder Information
| Metric | KMTS | TNDM |
|---|---|---|
| Shares Outstanding | 60M | 70M |
KMTS vs TNDM: stock comparison and AI forecast
Which is bigger, KMTS or TNDM?
KMTS is 1.3 times larger than TNDM by market capitalization ($1.77B against $1.33B).
Which one does Intratio's AI model rank higher, KMTS or TNDM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.